| 763848 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
247 The fully human antibody SRF617 is a potent inhibitor of ecto-enzyme CD39 in vivo |
2021-11-01 |
10.1136/jitc-2021-sitc2021.247 |
Matissek Stephan, Sicheva Marisella Panduro, Koseoglu Secil, Masia Ricard, Warren Michael, Rausch Matthew, Lee Benjamin, Pommey Sandra, Cousineau Isabelle, Stagg John, Palombella Vito, Lake Andrew |
| 763847 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
346 Translational program of the phase II MEDITREME trial: identification of prognostic factors for response to durvalumab and tremelimumab in combination with FOLFOX in metastatic colorectal cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.346 |
Thibaudin Marion, Ballot Elise, Limagne Emeric, Laheurte Caroline, Fumet Jean-David, Truntzer Caroline, Adotevi Olivier, Ghiringhelli François |
| 763846 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
100 Redirecting glucose flux during in vitro expansion improves the in vivo performance of adoptive T cell therapies for cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.100 |
Frisch Andrew, Wang Yiyang, Wang Yupeng, Lontos Konstantinos, Rivadeneira Dayana, Delgoffe Greg |
| 763845 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
296 A comprehensive clinical and genomic characterization of long-term responders receiving immune checkpoint blockade for metastatic non-small cell lung cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.296 |
Ghanem Paola, Murray Joseph, Hsu Melinda, Ettinger David, Feliciano Josephine, Forde Patrick, Hann Christine, Lam Vincent, Levy Benjamin, Brahmer Julie, Marrone Kristen |
| 763844 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
54 A strategy to quantitatively assess the accuracy and precision of multiplex immunofluorescence assays – application to Ultivue Insituplex® PD-L1, T-act and APC panels |
2021-11-01 |
10.1136/jitc-2021-sitc2021.054 |
Ram Sripad, Powell Eric |
| 763843 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
680 Isoforms of neuropilin-2 regulate distinct macrophage functions and are associated with unique tumor-associated macrophages in murine and human breast cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.680 |
Dhupar Rajeev, Jones Katherine, Powers Amy, Eisenberg Seth, Ding Kai, Chen Fangyuan, Nasarre Cecile, LaRue Amanda, Yeh Elizabeth, Luketich James, Lee Adrian, Oesterreich Steffi, Lotze Michael, Gemmill Robert, Soloff Adam |
| 763842 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
190 Patient-derived tumor organoids reveal mechanisms of immune evasion which can guide decisions in adoptive cell therapy for common epithelial cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.190 |
Parikh Anup, Parkhurst Maria, Robbins Paul, Rosenberg Steven, Yang James |
| 763841 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
599 Cyclophosphamide augments the efficacy of an in situ vaccine in a mouse melanoma model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.599 |
Tsarovsky Noah, Felder Mildred, Heck Mackenzie, Slowinski Jacob, Rasmussen Kayla, VandenHeuvel Sabrina, Morris Zachary, Erbe Amy, Sondel Paul, Rakhmilevich Alexander |
| 763840 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
118 Development of Claudin 18.2 TAC T cells for the treatment of gastric cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.118 |
Helsen Christopher, Benatar Tania, Philbert IP, Xu Stacey, Shaver Laura, Nitya-Nootan Thanyashanthi, Bader Andreas, Lal Prabha |
| 763839 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
267 Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes anti-tumor immunity and improves therapeutic window |
2021-11-01 |
10.1136/jitc-2021-sitc2021.267 |
Chen Shih-Hsun, Dominik Pawel, Stanfield Jessica, Ding Sheng, Yang Wenjing, Kurd Nadia, Llewellyn Ryan, Heyen Jonathan, Wang Carole, Melton Zea, Lindquist Kevin, Blarcom Thomas Van, Chaparro-riggers Javier, Salek-Ardakani Shahram |
